Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

JB Chemicals & Pharmaceuticals Ltd. (IN:JBCHEPHARM)

:JBCHEPHARM

JBCHEPHARM

JB Chemicals & Pharmaceuticals Ltd.

RESEARCH TOOLSreports

JB Chemicals & Pharmaceuticals Ltd. (JBCHEPHARM) Ratios

Compare

3 Followers

JB Chemicals & Pharmaceuticals Ltd. Ratios

IN:JBCHEPHARM's free cash flow for Q2 2026 was ₹0.68. For the 2026 fiscal year, IN:JBCHEPHARM's free cash flow was decreased by ₹ and operating cash flow was ₹0.26. See a summary of the company’s cash flow.

Ratios	TTM	Mar 25	Mar 24	Mar 23	Mar 22
Liquidity Ratios
Current Ratio	3.79	3.04	2.13	2.76	3.32
Quick Ratio	2.93	2.20	1.56	1.98	2.25
Cash Ratio	0.14	0.20	0.10	0.14	0.15
Solvency Ratio	1.02	0.99	0.65	0.49	0.98
Operating Cash Flow Ratio	0.54	1.43	0.92	1.13	0.44
Short-Term Operating Cash Flow Coverage	49.51	65.39	2.40	3.79	6.47
Net Current Asset Value	₹ 16.48B	₹ 10.82B	₹ 7.83B	₹ 4.55B	₹ 8.06B
Leverage Ratios
Debt-to-Assets Ratio	<0.01	<0.01	0.09	0.16	0.02
Debt-to-Equity Ratio	0.01	<0.01	0.13	0.23	0.03
Debt-to-Capital Ratio	0.01	<0.01	0.11	0.19	0.02
Long-Term Debt-to-Capital Ratio	0.00	0.00	<0.01	0.13	0.00
Financial Leverage Ratio	1.24	1.24	1.37	1.43	1.22
Debt Service Coverage Ratio	70.20	31.49	1.94	2.78	15.28
Interest Coverage Ratio	346.60	163.16	17.01	16.21	115.94
Debt to Market Cap	<0.01	<0.01	0.01	0.04	<0.01
Interest Debt Per Share	2.98	2.50	27.23	39.35	7.57
Net Debt to EBITDA	-0.04	-0.10	0.31	0.70	>-0.01
Profitability Margins
Gross Profit Margin	56.66%	66.40%	38.63%	35.76%	64.39%
EBIT Margin	23.90%	21.97%	22.82%	18.95%	20.99%
EBITDA Margin	28.08%	26.34%	26.79%	22.60%	23.99%
Operating Profit Margin	47.86%	48.85%	21.65%	18.76%	18.99%
Pretax Profit Margin	24.10%	22.65%	21.57%	17.82%	20.83%
Net Profit Margin	17.98%	16.83%	15.86%	13.15%	15.90%
Continuous Operations Profit Margin	17.98%	16.83%	15.86%	13.16%	15.92%
Net Income Per EBT	74.58%	74.33%	73.54%	73.81%	76.32%
EBT Per EBIT	50.36%	46.37%	99.65%	94.99%	109.65%
Return on Assets (ROA)	16.00%	15.43%	13.84%	11.53%	14.78%
Return on Equity (ROE)	21.72%	19.21%	18.90%	16.52%	18.06%
Return on Capital Employed (ROCE)	49.70%	52.56%	24.13%	19.49%	20.71%
Return on Invested Capital (ROIC)	36.89%	38.83%	15.98%	13.60%	15.59%
Return on Tangible Assets	22.29%	22.75%	21.69%	18.85%	20.51%
Earnings Yield	2.25%	2.68%	2.10%	2.68%	3.16%
Efficiency Ratios
Receivables Turnover	4.47	4.35	4.95	5.14	4.05
Payables Turnover	4.44	3.21	5.95	8.45	3.85
Inventory Turnover	3.15	2.49	4.22	4.68	2.11
Fixed Asset Turnover	6.18	5.97	5.49	5.41	4.28
Asset Turnover	0.89	0.92	0.87	0.88	0.93
Working Capital Turnover Ratio	4.46	3.44	3.56	3.34	2.31
Cash Conversion Cycle	115.19	116.77	98.93	105.79	168.47
Days of Sales Outstanding	81.68	83.99	73.78	71.05	90.05
Days of Inventory Outstanding	115.80	146.65	86.45	77.96	173.32
Days of Payables Outstanding	82.29	113.87	61.30	43.22	94.90
Operating Cycle	197.48	230.63	160.23	149.01	263.37
Cash Flow Ratios
Operating Cash Flow Per Share	23.14	56.86	51.67	40.45	22.00
Free Cash Flow Per Share	20.15	50.71	34.80	-9.01	-69.40
CapEx Per Share	2.98	6.15	16.87	49.46	91.41
Free Cash Flow to Operating Cash Flow	0.87	0.89	0.67	-0.22	-3.15
Dividend Paid and CapEx Coverage Ratio	2.32	2.70	1.91	0.70	0.20
Capital Expenditure Coverage Ratio	7.76	9.25	3.06	0.82	0.24
Operating Cash Flow Coverage Ratio	8.86	32.36	2.12	1.09	3.12
Operating Cash Flow to Sales Ratio	0.09	0.23	0.23	0.20	0.07
Free Cash Flow Yield	0.92%	3.27%	2.05%	-0.91%	-4.41%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	44.44	37.30	47.54	37.29	31.60
Price-to-Sales (P/S) Ratio	8.19	6.28	7.54	4.90	5.02
Price-to-Book (P/B) Ratio	8.80	7.17	8.99	6.16	5.71
Price-to-Free Cash Flow (P/FCF) Ratio	108.75	30.57	48.72	-109.68	-22.69
Price-to-Operating Cash Flow Ratio	92.44	27.27	32.82	24.43	71.58
Price-to-Earnings Growth (PEG) Ratio	9.44	1.96	1.38	5.92	-2.26
Price-to-Fair Value	8.80	7.17	8.99	6.16	5.71
Enterprise Value Multiple	29.12	23.75	28.46	22.40	20.94
Enterprise Value	342.84B	245.04B	265.62B	157.78B	121.76B
EV to EBITDA	29.12	23.75	28.46	22.40	20.94
EV to Sales	8.18	6.25	7.62	5.06	5.02
EV to Free Cash Flow	108.59	30.45	49.26	-113.23	-22.69
EV to Operating Cash Flow	94.60	27.15	33.18	25.22	71.57
Tangible Book Value Per Share	158.01	129.72	95.35	71.17	182.32
Shareholders’ Equity Per Share	242.94	216.33	188.66	160.38	276.00
Tax and Other Ratios
Effective Tax Rate	0.25	0.26	0.26	0.26	0.24
Revenue Per Share	267.67	246.87	224.86	201.52	313.52
Net Income Per Share	48.12	41.56	35.66	26.50	49.84
Tax Burden	0.75	0.74	0.74	0.74	0.76
Interest Burden	1.01	1.03	0.95	0.94	0.99
Research & Development to Revenue	<0.01	0.01	<0.01	0.01	0.01
SG&A to Revenue	0.04	<0.01	0.17	0.18	0.18
Stock-Based Compensation to Revenue	0.01	0.01	0.01	0.02	0.03
Income Quality	0.39	1.37	1.45	1.13	0.34

Currency in INR